The IU Center for Global Health and the Indiana Clinical and Translational Sciences Institute (CTSI) have officially released the reciprocal innovation demonstration grant.
There will be an informational webinar to provide deeper insight into the new reciprocal innovation request for application (RFA) and answer any questions. This session will be recorded.
Please add this to your calendar if you are interested in attending:
Date: December 8, 2021
Time: 9:00 AM (EST)/ 5:00 PM (EAT)
Location: https://iu.zoom.us/j/83869001840?pwd=R0w1RkcvTHhGcUcvSmUzSFo0MFdsZz09
Meeting ID: 838 6900 1840
Password: 215702
For this round of funding, reciprocal innovation grant applications should focus on one of these priority areas:
- Non-communicable diseases, including cancer, diabetes, and hypertension.
- Infant and maternal health
- Infectious diseases, especially HIV, malaria, and COVID-19.
- Mental health
- Health systems and access to quality health care, including health workforce capacity building, health care technologies, health financing, and community-based care.
Awards are up to $50,000 for a period of two years. This award is designed to support research and demonstrate innovations with a high potential to alleviate the health burden of one of the priority areas. Projects should result in high impact solutions that provide reciprocal benefit to the communities Indiana CTSI institutions serve either at home or abroad, as well as a plan to sustain and expand these efforts after the end of support from this RFA. Eligible proposals are collaborative and must include a principal investigator/project director from an Indiana CTSI partner institution (IU, Purdue, and Notre Dame) and at least one co-investigator or collaborator from a low- or middle-income partner institution.
The Reciprocal Innovation demonstration grant letter of intent deadline is January 14, 2022.
The full application submission deadline is March 1, 2022.
